scholarly journals Erratum for Gross et al., Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia

2014 ◽  
Vol 58 (10) ◽  
pp. 6342-6342 ◽  
Author(s):  
Alan E. Gross ◽  
Trevor C. Van Schooneveld ◽  
Keith M. Olsen ◽  
Mark E. Rupp ◽  
Thu Hong Bui ◽  
...  
Keyword(s):  
Health Care ◽  
Multidrug Resistant ◽  
Health Care Associated Pneumonia

scholarly journals Management of Health-Care Associated Pneumonia (HCAP)

2013 ◽  
pp. 87-90
Author(s):  
Alessia Rosato ◽  
Claudio Santini
Keyword(s):  
Health Care ◽  
Treatment Approach ◽  
Multidrug Resistant ◽  
Outpatient Setting ◽  
Community Acquired Pneumonia ◽  
Traditional Classification ◽  
Hospital Acquired Pneumonia ◽  
Health Care Associated Pneumonia ◽  
Hospital Acquired

Introduction The traditional classification of Pneumonia as either community acquired (CAP) or hospital acquired (HAP) reflects deep differences in the etiology, pathogenesis, approach and prognosis between the two entities. Health-Care Associated Pneumonia (HCAP) develops in a heterogeneous group of patients receiving invasive medical care or surgical procedures in an outpatient setting. For epidemiology and outcomes, HCAP closely resembles HAP and possibly requires an analogous therapeutic regimen effective against multidrug-resistant pathogens. Materials and methods We reviewed the pertinent literature and the guidelines for the diagnosis and management of HCAP to analyze the evidence for the recommended approach. Results Growing evidence seems to confirm the differences in epidemiology and outcome between HCAP and CAP but fails to confirm any real advantage in pursuing an aggressive treatment for all HCAP and CAP patients. Discussion Further investigations are needed to establish the optimal treatment approach according to the different categories of patients and the different illness severities. Keywords Health Care Associated Pneumonia (HCAP); Community Acquired Pneumonia (CAP); Hospital Acquired Pneumonia (HAP); Multidrug-resistant (MDR) Pathogens

scholarly journals Role of multidrug-resistant pathogens in health-care-associated pneumonia

2011 ◽  
Vol 11 (1) ◽  
pp. 11-12 ◽  
Author(s):  
Marco Falcone ◽  
Mario Venditti ◽  
Salvatore Corrao ◽  
Pietro Serra
Keyword(s):  
Health Care ◽  
Multidrug Resistant ◽  
Multidrug Resistant Pathogens ◽  
Health Care Associated Pneumonia

scholarly journals Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia

2014 ◽  
Vol 58 (9) ◽  
pp. 5262-5268 ◽  
Author(s):  
Alan E. Gross ◽  
Trevor C. Van Schooneveld ◽  
Keith M. Olsen ◽  
Mark E. Rupp ◽  
Thu Hong Bui ◽  
...  
Keyword(s):  
Risk Factors ◽  
Health Care ◽  
Wound Care ◽  
Medical Center ◽  
Multidrug Resistant ◽  
Resistant Organism ◽  
Content Type ◽  
Therapeutic Decisions ◽  
Health Care Associated Pneumonia ◽  
Community Onset

ABSTRACTThere are limited U.S. data describing the risk factors for multidrug-resistant organism (MDRO) isolation in community-acquired pneumonia (CAP) and health care-associated pneumonia (HCAP). However, concern for the presence of these pathogens drives the prescribing of empiric broad-spectrum antibiotics for CAP and HCAP. A retrospective study of all adults hospitalized with community-onset pneumonia (CAP and HCAP) at a large U.S. medical center from January 2010 to December 2011 was conducted. The objective was to ascertain the rate of pneumonia caused by MDROs and to evaluate whether HCAP is a risk factor for MDRO pneumonia. Univariate and propensity score-adjusted multivariate analyses were performed. A total of 521 patients (50.5% CAP and 49.5% HCAP) were included. The most common etiologies of pneumonia were primary viral andStreptococcus pneumoniae. MDROs were isolated in 20 (3.8%) patients overall, and MDROs occurred in 5.9% and 1.9% of HCAP and CAP patients, respectively. The presence of an MDRO was not associated with HCAP classification (odds ratio [OR] = 1.95; 95% confidence interval [95% CI], 0.66 to 5.80;P= 0.23) or with most of its individual components (hemodialysis, home infusion, home wound care, and ≥48-h hospitalization in the last 90 days). Independent predictors of MDRO included the following:Pseudomonas aeruginosacolonization/infection in the previous year (OR = 7.43; 95% CI, 2.24 to 24.61;P< 0.001), antimicrobial use in the previous 90 days (OR = 2.90; 95% CI, 1.13 to 7.45;P= 0.027), admission from a nursing home (OR = 4.19; 95% CI, 1.55 to 11.31;P= 0.005), and duration of hospitalization in the previous 90 or 180 days (P= 0.013 andP= 0.002, respectively). MDROs were uncommon in HCAP and CAP. HCAP did not predict MDRO isolation. Local etiology of community onset pneumonia and specific MDRO risk factors should be integrated into therapeutic decisions to prevent empirical overprescribing of antibiotics for methicillin-resistantStaphylococcus aureus(MRSA) andP. aeruginosa.

Health-Care Associated Pneumonia (HCAP): Identification of Low and High-Risk Patients

2015 ◽  
Vol 11 (3) ◽  
pp. 241-246 ◽  
Author(s):  
John Abisheganaden ◽  
Yew Ding ◽  
Wai Chong ◽  
Bee Heng ◽  
Akash Verma ◽  
...  
Keyword(s):  
Health Care ◽  
High Risk ◽  
High Risk Patients ◽  
Risk Patients ◽  
Health Care Associated Pneumonia
Sign in / Sign up

Export Citation Format

Share Document